Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Thymoglobulin (ATG) Dose Finding Study

This study has been terminated.
(Lack of Accrual)
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: December 7, 2006
Last updated: January 19, 2012
Last verified: January 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2007
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)